Literature DB >> 22622949

18-fluoro-deoxy-glucose positron emission tomography with computed tomography-based gross tumor volume estimation and validation with magnetic resonance imaging for locally advanced cervical cancers.

Maheshkumar N Upasani1, Umesh M Mahantshetty, Venkatesh Rangarajan, Nilendu Purandare, Nikhil Merchant, Meenakshi Thakur, Reena Engineer, Supriya Chopra, Shyam Kishore Shrivastava.   

Abstract

PURPOSE: Anatomy and morphology-based imaging is routinely used for radiotherapy purpose to deliver precision treatment. There is an interest in using information from functional imaging for conformal radiation therapy planning. These functional imaging techniques need to be validated rigorously before their routine use. We attempted to evaluate and validate the use of 18-fluoro-deoxy-glucose positron emission tomography with computed tomography (¹⁸FDG PET-CT) on primary tumor of the cervical carcinoma, with an aim of arriving at a cutoff maximum standardized uptake value (SUVmax) at which the tumor volume correlates best with magnetic resonance imaging (MRI). This observational study was a part of an ethics committee-approved study evaluating pretreatment MRI and FDG PET-CT.
MATERIALS AND METHODS: Patients' biopsy-proven cervical carcinomas (stages IIB and IIIB) were included in this study and underwent pretreatment MRI and FDG PET-CT as per institutional protocol. Volumes of the disease at the cervix on the MR image were calculated. Volumes at the FDG PET-CT scan at different percentages of SUVmax were auto contoured. Volume at MRI was correlated with each different percentage cutoff of the SUVmax.
RESULTS: Data of 74 patients were available for the study. The mean (SD) SUVmax of the primary tumor was 15.7 (7.0). The mean MRI volume correlates significantly (P < 0.001) with 30% and 35% of SUVmax values with good correlation according to the Pearson bivariate correlation (r = 0.79 each). The mean difference between MRI and PET volumes was least with 30% SUVmax.
CONCLUSIONS: ¹⁸FDG PET-CT SUV-based primary tumor volume estimation at 30% to 35% of SUVmax values correlates significantly with the criterion standard MR volumes for primary cervical tumor with squamous histology in our population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22622949     DOI: 10.1097/IGC.0b013e318251046b

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  7 in total

1.  Anatomical and functional volume concordance between FDG PET, and T2 and diffusion-weighted MRI for cervical cancer: a hybrid PET/MR study.

Authors:  Hongzan Sun; Jun Xin; Shaomin Zhang; Qiyong Guo; Yueyue Lu; Wei Zhai; Long Zhao; Weiai Peng; Baijun Wang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01-25       Impact factor: 9.236

Review 2.  Evaluating the Use of 18F-FDG PET CT for External Beam Radiotherapy Planning in Gynaecological Malignancies.

Authors:  Ashleigh Kerr; Nicholas Reed; Rosie Harrand; Kathryn Graham; Azmat H Sadozye
Journal:  Curr Oncol Rep       Date:  2018-09-11       Impact factor: 5.075

3.  Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography.

Authors:  Mubarik A Arshad; Samuel Gitau; Henry Tam; Won-Ho E Park; Neva H Patel; Andrea Rockall; Eric O Aboagye; Nishat Bharwani; Tara D Barwick
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-12-11       Impact factor: 9.236

4.  Concordance of FDG PET/CT metabolic tumour volume versus DW-MRI functional tumour volume with T2-weighted anatomical tumour volume in cervical cancer.

Authors:  Alta Y T Lai; Jose A U Perucho; Xiaopei Xu; Edward S Hui; Elaine Y P Lee
Journal:  BMC Cancer       Date:  2017-12-06       Impact factor: 4.430

5.  Impact of suboptimal dosimetric coverage of pretherapeutic 18F-FDG PET/CT hotspots on outcome in patients with locally advanced cervical cancer treated with chemoradiotherapy followed by brachytherapy.

Authors:  François Lucia; Vincent Bourbonne; Dorothy Gujral; Gurvan Dissaux; Omar Miranda; Maelle Mauguen; Olivier Pradier; Ronan Abgral; Ulrike Schick
Journal:  Clin Transl Radiat Oncol       Date:  2020-05-11

6.  Use of Baseline 18 F-FDG PET/CT to Identify Initial Sub-Volumes Associated With Local Failure After Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer.

Authors:  François Lucia; Omar Miranda; Ronan Abgral; Vincent Bourbonne; Gurvan Dissaux; Olivier Pradier; Mathieu Hatt; Ulrike Schick
Journal:  Front Oncol       Date:  2020-05-07       Impact factor: 6.244

7.  Automated biological target volume delineation for radiotherapy treatment planning using FDG-PET/CT.

Authors:  Maximilian Niyazi; Sonja Landrock; Andreas Elsner; Farkhad Manapov; Marcus Hacker; Claus Belka; Ute Ganswindt
Journal:  Radiat Oncol       Date:  2013-07-12       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.